Showing results (401-410 of 1,285) with videos related to

Sort By:
Pageof 129
Frontiers in Oncology|January 29, 2021
Hormonal Receptor Immunochemistry Heterogeneity and 18F-FDG Metabolic Heterogeneity: Preliminary Results of Their Relationship and Prognostic Value in Luminal Non-Metastatic Breast CancersNicolas Aide, Nicolas Elie, Cécile Blanc-Fournier, et al.
Molecular Imaging and Biology|April 1, 2009
Early 2'-deoxy-2'-[18F]fluoro-D-glucose PET metabolic response after corticosteroid therapy to differentiate cancer from sarcoidosis and sarcoid-like lesionsNicolas Aide, Djelila Allouache, Yann Ollivier, et al.
EJNMMI Research|December 5, 2018
Optimization of a dedicated protocol using a small-voxel PSF reconstruction for head-and-neck 18FDG PET/CT imaging in differentiated thyroid cancerRenaud Ciappuccini, Cédric Desmonts, Idlir Licaj, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 19, 2010
Use of lymphoscintigraphy in radiation treatment of primary breast cancer in the context of lymphedema risk reductionIndra J Das, Andrea L Cheville, Joshua Scheuermann, et al.
Brain Research|July 25, 2006
Assessment of regional blood flow in cerebral motor and sensory areas in patients with spinal cord injuryTevfik Fikret Cermik, Hakan Tuna, Meryem Kaya, et al.
Cerebral Cortex (New York, N.Y. : 1991)|June 7, 2008
Regional differences in the coupling between resting cerebral blood flow and metabolism may indicate action preparedness as a default stateRuben C Gur, J Daniel Ragland, Martin Reivich, et al.
Clinical Nuclear Medicine|September 21, 2022
Monitoring the Progression of a Calcifying Uterine Leiomyoma: Detection Using 18 F-NaF-PET/CTDavid A Resto, Peter Sang Uk Park, Thomas J Werner, et al.
Diagnostics (Basel, Switzerland)|July 14, 2023
18F-FDG and 18F-NaF PET/CT Global Assessment of Large Joint Inflammation and Bone Turnover in Rheumatoid ArthritisNatasha Reddy, William Y Raynor, Thomas J Werner, et al.
Cancer|December 22, 2007
Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterizationSandip Basu, Wengen Chen, Julia Tchou, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|March 11, 2016
Role of Optimal Quantification of FDG PET Imaging in the Clinical Practice of RadiologyPouya Ziai, Mohammad Reza Hayeri, Aliaksei Salei, et al.
Pageof 129